## CHRW: C.H. Robinson Worldwide, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 1.6% below STRENGTH zone (4.0-10.0%); PEG 2.25 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($149.91)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Is C.H. Robinson Stock Outperforming the Dow?**
- Source: Markets Financial Content | 20251216T070736 | Bullish | Relevance: 100%
- C.H. Robinson Worldwide, Inc. (CHRW) stock has significantly outperformed the Dow Jones Industrial Average, with gains of 18.3% in three months, 41.5% in 52 weeks, and 52.6% year-to-date. This strong performance is supported by robust Q3 2025 adjusted EPS growth and an increased 2026 operating income target. Wall Street analysts maintain a "Moderate Buy" rating for CHRW, indicating continued confidence in its trajectory.

**2. Is C.H. Robinson Stock Outperforming the Dow?**
- Source: Barchart.com | 20251216T073037 | Bullish | Relevance: 100%
- C.H. Robinson Worldwide, Inc. (CHRW) stock has significantly outperformed the Dow Jones Industrial Average ($DOWI) over the past three months, 52 weeks, and year-to-date, signaling strong investor confidence despite revenue declines. The company reaffirmed its profitability narrative by raising its 2026 operating income target and trading above analyst price targets, with a "Moderate Buy" rating. This performance also outpaces its rival, Expeditors International of Washington, Inc. (EXPD).

**3. \Balyasny Asset Management L.P. Has $100.44 Million Stake in C.H. Robinson Worldwide, Inc. $CHRW**
- Source: MarketBeat | 20251213T090754 | Neutral | Relevance: 100%
- Balyasny Asset Management L.P. has reduced its stake in C.H. Robinson Worldwide (NASDAQ:CHRW) by 18.6%, now owning 1,046,789 shares valued at approximately $100.44 million. The transportation company recently reported quarterly EPS of $1.40, exceeding estimates, and increased its quarterly dividend to $0.63. Analysts have a "Moderate Buy" consensus rating for CHRW with an average target price of $143.35.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | Morgan Stanley | $85 | $77 | +10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | Morgan Stanley | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 4 ($1.86M) |
| Sells | 2 ($0.38M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 54.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.0% (-3.0%)
- First Eagle Investme: 8.9% (-0.2%)
- Blackrock Inc.: 8.2% (-8.5%)
- Wellington Managemen: 6.1% (+198.6%)
- State Street Corpora: 5.8% (-7.4%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_20 improving +4.8% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.25 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 34%). Analyst sentiment positive (1 raises, avg +10%). Insider buying signal ($1.9M), management confidence. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $18.6B |
| Beta | 0.91 |
| 52W Range | $84.68 - $162.79 |
| Short Interest | 7.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.25 |
| Forward P/E | 26.4 |
| Current P/E | 31.6 |
| YoY Growth | 19.8% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -3.2% to 1.6% (+4.8% in 5 days), confirming momentum buildup. Below STRENGTH zone by 2.4pp (needs >4.0% for momentum thesis). MRS_5 at 1.9% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram bearish (-0.71), momentum weakening. RSI neutral at 58. OFD pattern: +SLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.57% (CS: 48) | Neutral |
| RSI_14 | 58.2 | Neutral |
| MACD Histogram | -0.71 | Bearish |
| vs SMA20 | 1.010x | Above |
| vs SMA50 | 1.086x | Above |
| vs SMA200 | 1.366x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $157.61
- **Stop Loss:** $149.91 (4.9% risk)
- **Target:** $165.31 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 155
- **Position Value:** $24,429.55
- **Portfolio %:** 24.43%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-01-28 (Est: $1.13)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.30 | $1.40 | +7.4% |
| 2025Q2 | $1.16 | $1.29 | +11.6% |
| 2025Q1 | $1.05 | $1.17 | +11.4% |
| 2024Q4 | $1.11 | $1.21 | +9.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*